There are ongoing and proactive efforts among various stakeholders in finding effective treatments for atopic dermatitis, also commonly known as eczema. Here is a brief review of some of 3 new treatments for eczema that you may like to know.
- Wet Wrap Therapy
The National Institute of Allergy and Infectious Diseases (NIIAID) as well as other institutions is currently researching the ‘wet wrap’ therapy for eczema. This particular treatment is usually intended to assist patients suffering from the severe variety of this chronic inflammatory skin condition. Essentially, it entails the patients taking 3 lukewarm baths on a daily basis. These baths are then followed up by the application of topical eczema medication and moisturizer, which is then sealed in wraps of wet gauze. These wraps greatly assist in keeping the patient’s skin moist and also enhance the effectiveness of topical medication. They have an anti itch effect as well.
Dupixent is an eczema injection that has been made for adult patients who suffer from a moderate or even severe form of this skin condition. This is particularly the case for those who have failed to obtain any relief from topical remedies. On the 28th of March 2017, the FDA released a press release announcing it had approved this atopic dermatitis therapy. Generally speaking, it is administered via an intravenous injection and its active ingredient is a type of antibody that is referred to as dupilimab. This antibody carries out its function by binding itself to the protein IL – 4 that triggers inflammation.
When this binding takes place, the inflammatory response, which plays a key role in the development of eczema, is inhibited. It is important to take note of the fact that the efficacy along with safety of Dupixent was clearly proved in 3 different placebo oriented clinical trials. With most of the 2,119 participants attaining better responses and significant reduction in itching after only sixteen weeks of undergoing treatment.
- Bacteria treatment for eczema
Dermatologists from the University of California at San Diego very recently developed an innovative microbial therapy for atopic dermatitis. These dermatologists led by Dr. Richard Gallo discovered that 2 harmless bacteria present on the skin possess an uncanny ability of killing one of the bacteria, which is known to play a key role in eczema. The harmless bacteria are staphylococcus hominis together with staphylococcus epidermis. While the detrimental one is known as staphylococcus aureus.
The researchers first swabbed off the first 2 from the skins of volunteers suffering from the condition. They then grew them in the laboratory before integrating them into an easy to apply lotion, which they ultimately supplied the volunteers with. When used on the forearms, this lotion dramatically increased the levels of the 2 friendly bacteria. This in turn led them to virtually get rid of staphylococcus aureus in just 24 hours after application.
According to Elizabeth Grice, a University of Pennsylvania research dermatologist and microbiologist, this was the very first time anything of this kind had been demonstrated. She added, it remained to be witnessed if this treatment could help minimize the severity of atopic dermatitis in the long term.